Publicaciones en VIVO

Mapa de la ciencia

Red de Coinvestigador

MURIEL SERRANO, JAVIER

Person (Active)

Positions

TITULADOS SUPERIORES I, Medicina Clínica 2020 -
TITULADOS SUPERIORES I, Medicina Clínica 2021 -
Profesor/a Asociado/a, Farmacología, Pediatría y Química Orgánica 2021 -
Profesor/a Ayudante Doctor/a, Farmacología, Pediatría y Química Orgánica 2024 -
Contratado/a Laboral, Farmacología, Pediatría y Química Orgánica 2018 - 2019

Publications
Research
Teaching
Contact
Otro
Ver todos

supported publications or other works

selected publications

academic article
- Clinical prediction of opioid use disorder in chronic pain patients: a cohort-retrospective study with a pharmacogenetic approach. MINERVA ANESTESIOLOGICA. 386-396. 2024
- Epigenetic and sex differences in opioid use disorder in chronic pain: A real-world study linked with OPRM1 DNA methylation. ADDICTION BIOLOGY. 2024
- Erectile dysfunction in cardiovascular patients: A prospective study of the eNOS gene T-786C, G894T, and INTRON variable number of the tandem repeat functional interaction. ANDROLOGY. 2024
- Predictive model for opioid use disorder in chronic pain: a development and validation study. BIOMEDICINES. 1-11. 2024
- Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives. DRUG METABOLISM AND PERSONALIZED THERAPY. 2024
- Use of CYP2D6 substrates and inhibitors during pain management with analgesic opioids: Drug-drug interactions that lead to lack of analgesic effectiveness. BIOMEDICINE & PHARMACOTHERAPY. 2024
- CYP2D6 Genotype and Pharmacovigilance Impact on Autism Spectrum Disorder: A Naturalistic Study with Extreme Phenotype Analysis. PHARMACEUTICALS. 2023
- Farmacogenética y respuesta analgésica: hacia una medicina personalizada con análisis de las diferencias por sexo / Pharmacogenetics in analgesic response: towards a sex-differences personalized medicine. REVISTA DE LA SOCIEDAD ESPAÑOLA DEL DOLOR. 115-124. 2023
- Impact of CYP2D6 genotype on opioid use disorder deprescription: an observational prospective study in chronic pain with sex-differences. FRONTIERS IN PHARMACOLOGY. 120043-120043. 2023
- Long-terms deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences. ACTA PHARMACEUTICA. 227-241. 2023
- Pharmacogenetic Guided Opioid Therapy Improves Chronic Pain Outcomes and Comorbid Mental Health: A Randomized, Double-Blind, Controlled Study. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2023
- CYP2D6 phenotypes and opioid metabolism: the path to personalized analgesia. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY. 261-275. 2022
- Food Protein-Induced Enterocolitis Syndrome in Adulthood: Clinical Characteristics, Prognosis, and Risk Factors. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE. 2397-2403. 2022
- Oxycodone/naloxone versus tapentadol in real¿world chronic non¿cancer pain management: an observational and pharmacogenetic study. SCIENTIFIC REPORTS. 1-12. 2022
- Sex Differences in Oxycodone/Naloxone vs. Tapentadol in Chronic Non-Cancer Pain: An Observational Real-World Study. BIOMEDICINES. 2022
- Sex-differences in pain and opioid use disorder management: a cross-sectional real-world study. BIOMEDICINES. 1-11. 2022
- Therapeutic alliance impact on analgesic outcomes in a real-world clinical setting: An observational study. ACTA PHARMACEUTICA. 524-545. 2022
- Global Pain State questionnaire: reliability, validity, and gender gap. ARCHIVES OF INTERNAL MEDICINE RESEARCH. 84-106. 2021
- Interplay of circadian clock and melatonin pathway gene variants in adults with autism, intellectual disability and sleep problems. RESEARCH IN AUTISM SPECTRUM DISORDERS. 1-12. 2021
- Gender based differences, pharmacogenetics and adverse events in chronic pain management. PHARMACOGENOMICS JOURNAL. 320-328. 2020
- Personality and psychiatric disorders in chronic pain male affected by erectile dysfunction: prospective and observational study. INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH. 339-347. 2020
- Health benefits of an adverse events reporting system for chronic pain patients using long¿term opioids. ACTA ANAESTHESIOLOGICA SCANDINAVICA. 248-258. 2018
- OPRM1 influence on and effectiveness of an individualized treatment plan for prescription opioid use disorder patients. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 82-93. 2018
chapter
- Enfermedad de Marfan y Síndromes relacionados. ENFERMEDADES MINORITARIAS EN EL ADULTO (2ª Edición). 268-279. 2021
congress communication
thesis
- TRATAMIENTO DEL TRASTORNO POR CONSUMO DE OPIOIDES DE PRESCRIPCIÓN EN PACIENTES CON DOLOR CRÓNICO NO ONCOLÓGICO: EFECTIVIDAD, SEGURIDAD Y MARCADORES FARMACOGENÉTICOS 2019